Document is current
Any future updates will be listed below
-
Authors
Suzuki, Keisuke
Suzuki, Shiho
Fujita, Hiroaki
Kobayashi, Saro
Shioda, Mukuto
Hida, Ryotaro
Hirata, Koichi
-
Funding
Funding for this research was provided by:
Ministry of Health, Labour and Welfare Research, Japan (23FC1058)
- License Information
-
More Information
Article History
Received: 7 January 2025
Accepted: 10 February 2025
First Online: 19 February 2025
Declarations
:
: The study was conducted in compliance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Dokkyo Medical University Hospital (approval number: R-89–1 J). The Institutional Review Board of Dokkyo Medical University Hospital waived the requirement for patients to sign informed consent forms on the basis of the retrospective, observational nature of the study.
: Not applicable.
: The authors declare the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article. K Suzuki received lecture fees from Eli Lilly Japan, Daiichi Sankyo and Otsuka Pharmaceutical Co., Ltd., during the study. S Suzuki received lecture fees from Eli Lilly Japan, Daiichi Sankyo, Amgen and Otsuka Pharmaceutical Co., Ltd., during the study. H Fujita, S Kobayashi, M Shioda and R Hida have nothing to disclose. K Hirata received lecture fees from Eli Lilly Japan, Daiichi Sankyo, Amgen and Otsuka Pharmaceutical Co., Ltd., during the study.
